GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Middle East Pharmaceutical Industries Company SJSC 4016.SR · SAR

Health Care · Tadawul · 🇸🇦 Saudi Arabia

Compare

62.05

-2.97%

Close of 9 Nov 2026, in SAR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

9 analysts, 1 Feb 2026. The analysts' own views, not ours.

  • 0Strong buy
  • 0Buy
  • 3Hold
  • 4Sell
  • 2Strong sell

Price targets

Brokers' own targets, 1 Feb 2026. Not our view.

Average target 135.66

Low
134.33
Average
135.66
Median
135.66
High
139.65

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028FY2029FY2030
RevenueSAR 535.0mSAR 590.0mSAR 648.0mSAR 734.0mSAR 833.0m
Revenue, highestSAR 535.0mSAR 590.0mSAR 648.0mSAR 734.0mSAR 833.0m
Revenue, lowestSAR 535.0mSAR 590.0mSAR 648.0mSAR 734.0mSAR 833.0m
Earnings per share3.103.503.904.204.90
Earnings per share, highest3.103.503.904.204.90
Earnings per share, lowest3.103.503.904.204.90
Analysts11111

Earnings against forecasts

Earnings per share by fiscal quarter

Q4 2025
Forecast2.27
Reported2.27
Difference0.0%

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

6 / 10

Revenue growth 0.0% a year over 10 years. Return on equity 23.3%.

Model fair value

58.43

From earnings 58.43, from revenue 90.86.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.